William W. Featheringill is Director & 10% at BIOCRYST PHARMACEUTICALS INC (BCRX). They have made 6 open-market trades across 1 company since 2000, most recently 2009-12-01.
CIK 0000946066
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $6.6M since 2000, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BCRX | 231,538 | $1.8M |
Shares reported on the most recent Form 4, priced at the 2009-12-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BCRX | SELL | 2009-12-01 | 2009-12-02 | $8.06 | $1.2M | -26.4% | -2.7% | -2.7% |
| BCRX | SELL | 2009-11-23 | 2009-11-25 | $9.56 | $132K | -26.4% | -2.7% | -2.7% |
| BCRX | SELL | 2009-11-20 | 2009-11-23 | $9.66 | $4.2M | -26.4% | -2.7% | -2.7% |
| BCRX | BUY | 2007-08-06 | 2007-08-08 | $7.80 | $6.5M | -26.4% | -2.7% | -2.7% |
| BCRX | SELL | 2006-02-10 | 2006-02-14 | $16.49 | $264K | -26.4% | -2.7% | -2.7% |
| BCRX | BUY | 2000-11-01 | 2009-03-05 | $9.00 | $99K | -26.4% | -2.7% | -2.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.